Hysteroscopic morcellation versus bipolar resection for removal of type 0 and 1 submucous myomas: A randomized trial

Comparison of Hysteroscopic Morcellation Versus Resectoscopy in Treatment of Patients with Endometrial Lesions: A Meta-Analysis

“…For this meta-analysis, according to our retrieval scheme and the inclusion and exclusion criteria, there were finally 6 studies including 565 patients that meet the requirements ( Figure 1 ), and the detailed literature screening process is shown in Table 1 . Forty-one patients were excluded for several reasons, and a total of 565 patients were included in 6 reports [ 7 – 12 ], including the experimental group, in which a hysteroscopic morcellator was used and the control group, in which conventional resectoscopy was used. The TRUCLEAN system was used for all patients in the experimental group, and electrocautery was used for all patients in the control group.…”

Focus on the Primary Prevention of Intrauterine Adhesions: Current Concept and Vision

“…The latter incorporates two main systems: the Truclear (Medtronic, Minneapolis, MN, USA), and the MyoSure (Hologic, Marlborough, MA, USA), both of which have been approved by the Food and Drug Administration (FDA) [ 73 , 74 , 79 ]. In theory, hysteroscopic tissue removal might cause less damage to the endometrial cavity than resectoscopic myomectomy dose, although no comparison studies have been conducted to evaluate the incidence of IUA in women with submucosal myomas treated either by hysteroscopic resectoscopy or by hysteroscopic mechanical morcellation [ 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 ]. By contrast, a comparison study has been carried out on the management of women with placental remnants [ 80 , 84 , 85 ].…”

“…By contrast, a comparison study has been carried out on the management of women with placental remnants [ 80 , 84 , 85 ]. The results showed that there were no statistically significant differences in adverse events, tissue availability, short-term effectiveness or postoperative IUAs when hysteroscopic morcellation and bipolar loop resection for the removal of placental remnants were compared [ 79 , 82 , 83 ].…”

“…In terms of preoperative procedures carried out before hysteroscopic tissue removal, some may increase the risk of IUA development. The most common clinical situations include a relatively large submucosal myoma, and the management of retained placenta (placenta remnants) and/or abnormal placentation, such as placenta previa, accrete, increta, and percreta [ 21 , 36 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 ]. Preoperative uterine artery embolization (UAE) or a similar procedure performed by surgeons (uterine vessel occlusion (UVO) either by laparoscopy or by exploratory laparotomy) may be an example [ 89 , 90 , 91 , 92 , 93 , 94 ].…”

“…A barrier can be achieved by two strategies; one uses agents and the other is physical or mechanical. Agents act as a barrier, can be solid form, liquid form (hydroflotation agents) or gel form, and the components include polyethylene oxide–sodium carboxymethylcellulose gel and crosslinked hyaluronic acid (CHA) gels [ 71 , 81 , 82 , 96 , 97 , 98 , 99 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 120 , 148 , 149 , 154 , 155 , 156 ]. Physical or mechanical barriers include intrauterine suitable balloon catheters, Foley balloon catheters, Malecot catheters, silicone sheets, and intrauterine devices (IUD) [ 73 , 103 , 104 , 105 , 106 , 107 , 108 ].…”